Biomarker: W011-IgE Thistle, Russian

Overview

This biomarker measures immunoglobulin E (IgE) antibodies directed against Russian thistle pollen, commonly associated with Salsola kali or related Salsola species. Russian thistle pollen is an aeroallergen associated with allergic rhinitis, conjunctivitis, asthma, and other seasonal allergic symptoms in sensitized individuals. A high result indicates immunologic sensitization to the tested pollen extract, but it does not by itself confirm symptomatic allergy or predict reaction severity. Testing is clinically useful when interpreted with exposure history, seasonal symptoms, physical findings, and other allergy-testing results.

Clinical Use Cases

Support evaluation of suspected Russian thistle pollen allergy.
Investigate seasonal allergic rhinitis or rhinoconjunctivitis.
Evaluate possible pollen-associated asthma.
Identify sensitization to Russian thistle as part of an inhalant-allergen assessment.
Help distinguish Russian thistle sensitization from related chenopod or weed-pollen sensitization when interpreted with component testing and clinical history.
Support allergen avoidance counseling and consideration of allergen immunotherapy in appropriately selected patients.

Specimen Types

Serum or plasma obtained from peripheral venous blood.
In selected research settings, serum samples may be analyzed alongside skin-prick-test results or component-specific IgE measurements.

Measurement Methods

Quantitative or semiquantitative in-vitro allergen-specific IgE immunoassay.
Enzyme-linked immunosorbent assay, or ELISA, in research and allergen-characterization studies.
Immunoblotting or immunoblot inhibition methods in research studies investigating individual Russian thistle allergens.
Skin-prick testing with Russian thistle pollen extract is a related, but separate, method for assessing immediate hypersensitivity and is not a measurement of circulating IgE.

Test Preparation and Influencing Factors

Fasting is generally not required for an allergen-specific IgE blood test.
Report all prescription medicines, over-the-counter medicines, vitamins, and supplements to the healthcare provider.
Do not stop antihistamines or other medicines unless specifically instructed. Antihistamines can affect skin-prick-test results, but generally do not interfere with measurement of circulating specific IgE.
Results should be interpreted with the patient’s exposure history, symptom timing, and clinical presentation. A positive result indicates sensitization and does not establish that exposure causes symptoms.
The IgE concentration does not reliably predict the severity of a future allergic reaction.
Results can vary with the allergen extract, assay platform, reporting units, analytical cutoff, and the specific Salsola species represented in the test.
Cross-reactive pollen allergens, including profilin and other shared plant proteins, may contribute to positive results and should be considered during interpretation.
A negative result does not completely exclude clinically relevant allergy when the history is strongly suggestive.